Latest Inflammatory breast cancer Stories
But second study finds a subset of patients who may not benefit.
But a Subset of Patients May not Need Chemo.
SAN ANTONIO, Dec. 10 /PRNewswire-FirstCall/ -- Genomic Health, Inc.
HUNTINGTON BEACH, California and AMSTERDAM, December 8 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, announced today that it will be presenting six studies focusing on MammaPrint(R) at the 2009 San Antonio Breast Cancer Symposium (SABCS), one of the premiere conferences in breast cancer research worldwide.
Even when informed about risks, benefits, only 6% would take drug.
IRVINE, Calif., Oct. 28 /PRNewswire/ -- Although Breast Cancer Awareness Month is coming to an end, smart women know that taking care of their health is important throughout the year.
For women just diagnosed with breast cancer, one of the important decisions confronting them is whether to have a lumpectomy or mastectomy.
Estrogen levels following menopause may impact risk of joint pain caused by drugs; electro-acupuncture proves helpful for alleviating symptoms.
ROCKVILLE, Md., Sept.
Drugs used to lower the risk of breast cancer in women have the side effect of increasing the likelihood of blood clots, researchers in Oregon say. The study, published in the current issue of Annals of Internal Medicine, examined the effects of tamoxifen, raloxifene and tibolone reduce the risk of invasive breast cancer by 30 percent to 68 percent.